To test the role of gene expression of the classical ER (ER␣) in the inhibitory effects of E on food intake and body weight, we ovariectomized and administered E2 benzoate (75 pg/d) or vehicle to wild-type (WT) mice and mice with a null mutation of ER␣ (␣ERKO). Mice were ovariectomized at age 9 wk, at which time there was no significant effect of genotype on food intake or body weight. During an 18-d test after recovery from ovariectomy, vehicle-treated WT mice increased daily food intake and gained more body weight than E2-treated WT mice, whereas food intake and body weight gain were not different in E2-and vehicle-treated ␣ERKO mice. Carcass analysis revealed parallel changes in body lipid content, but not water or protein content. Because an increase in the potency of the peripheral cholecystokinin (CCK) satiation-signaling system mediates part of E2's influence on feeding in rats, the influence of ip injections of 250 g of the selective CCK A receptor antagonist devazepide was then tested. Devazepide increased 3-h food intake in E2-treated WT mice, but was ineffective in both groups of ␣ERKO mice. Furthermore, ip injections of 4 g/kg CCK-8 increased the number of cells expressing c-Fos immunoreactivity in the nuclei of the solitary tract of E2-treated WT mice more than it did in vehicle-treated WT mice, whereas E2 had no such effect in ␣ERKO mice. Thus, ER␣ is necessary for normal responsivity of food intake, body weight, adiposity, and the peripheral CCK satiation-signaling system to E2 in mice, and ER␤ is not sufficient for any of these effects.
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This is the first demonstration that ER␣ gene expression is involved in the estrogenic control of feeding behavior and weight regulation of female mice. (Endocrinology 142: 4751-4757, 2001)

E2
ORCHESTRATES A variety of physiological and behavioral functions in adult females, resulting, presumably, in increased reproductive success (1) . In mice, rats, and many other mammals, the inhibition of feeding is one of these functions (2) (3) (4) (5) . This, together with estrogenic influences on activity and metabolism, provides a major control of adiposity and body weight (2) (3) (4) (5) (6) (7) (8) (9) . Studies of ovariectomy and E2 treatment reveal that in intact rats E2 both tonically reduces basal feeding throughout the ovarian cycle and cyclically reduces feeding during the estrous phase of the ovarian cycle (2, 3, 10 -12) . Both effects take the form of reductions in meal size without changes in meal number (2, 3, 13, 14) . E2 apparently influences meal size by modulating postingestive negative feedback signals, or satiation signals, that are elicited during meals by preabsorptive actions of ingested food (15) (16) (17) (18) . For example, during estrus, E2 increases the satiating potency of endogenous cholecystokinin (CCK) (10, 19) , a gut peptide that is part of the signaling mechanism by which intestinal food stimuli control meal size (15, 16, 18) . The mechanisms by which E2 modulates the action of this and other satiation signals, however, are poorly understood (2, 3, 20) .
There has been rapid progress in recent years in understanding the molecular biology of estrogenic actions (21, 22) . The classical ER, ER␣, was cloned and sequenced (23, 24) , and a second ER, ER␤, was identified (25) . In addition, gene targeting and transgenic methods were used to generate mice with a null mutation of the classical ER, ER␣ (␣ERKO mice) (26, 27) . Dozens of studies of the physiology and behavior of the ␣ERKO mouse have already appeared and indicate that although ER␣ is not essential for survival, it appears necessary for the normal expression of all the E2-dependent responses studied to date (reviewed in Ref. 21 ). Thus, for example, female ␣ERKO mice display aberrant social and reproductive behaviors that resemble those of intact males more than those of intact females (28, 29) . Little is known, however, about the feeding behavior of ␣ERKO mice. Heine et al. (6) reported that male ␣ERKO and wild-type (WT) mice eat virtually identical amounts through the first 11 months of life. Food intake in females was not reported. Body weight and adiposity were increased, however, in both male and female ␣ERKO mice by 3 months of age (6, 9) . Adiposity was also increased by 3 months of age in male and female aromatase-deficient mice, although these animals ate less, not more, than WT mice (7) . To further investigate the roles of E2 and ER␣ in the control of feeding and body weight, we tested the effects of ovariectomy and E2 treatment on food intake, body weight gain, and the behavioral and central neural responsivity to manipulation of the CCK satiation-signaling system in female ␣ERKO mice and their WT littermates. Our findings indicate that E2's effects on basal food intake, maintenance of body weight, and CCK satiation in female mice all require ER␣, and therefore by itself ER␤ is not sufficient.
Materials and Methods Subjects
Subjects were female ␣ERKO mice and WT littermates that were bred at Rockefeller University using a line of mixed C57BL/6J and 129 strain Abbreviations: CCK, Cholecystokinin; ␣ERKO, mice with a null mutation of ER␣; NTS, nucleus of the solitary tract; WT, wild type. mice in which the ER␣ gene was disrupted, as described previously (26, 27) . The experiments were performed with the approval of the Rockefeller University institutional animal care and use committee. At age 4 wk, litters of mice were separated from their dams and housed five or six per cage in plastic cages (30 ϫ 20 ϫ 13 cm) with ad libitum food (Purina 5001, Ralston Purina Co., St. Louis, MO) and water in a colony room with a 12-h light, 12-h dark cycle (lights on, 0700 h) and constant temperature (22 C). During wk 5 they were anesthetized with methoxyflurane (Metofane, Mallinckrodt, Inc., Mundelein, IL), and 1-mm tissue samples were taken from the tips of the tails and genotyped by PCR. During wk 7 about 20 each of the ␣ERKO and WT female mice were separated into individual cages, and during wk 8 body weights (Ϯ0.1 g), 24-h food intakes (Ϯ0.01 g), and smears of the vaginal mucosa were obtained daily.
Ovariectomy and E2 treatment
At 9 wk of age, mice were bilaterally ovariectomized under methoxyflurane anesthesia. Ovaries were exposed via a single midline skin incision and bilateral penetrations of the retroperitoneal musculature with fine forceps. A 5-0 silk ligature was placed between the ovary and the tip of the uterine horn, and the ovary was excised. A pellet containing either E2 or vehicle alone was placed into the interscapular sc space (Innovative Research of America, Sarasota, FL; pellets weighed 15 mg and contained 180 g ␤-E2 3-benzoate in a carrier-binder matrix of cholesterol, lactose, cellulose, phosphates, and stearates that released a constant dose of 75 pg/d). The muscle was closed with silk suture, and the skin was closed with 9-mm wound clips. There were seven to nine roughly weight-matched mice per treatment group. After recovery from surgery, they were tested sequentially in the procedures described below.
Food intake and body weight
Although some mice were hypophagic for several days after ovariectomy, all returned to preoperative levels of food intake and body weight by 1 wk postsurgery. Daily ad libitum food intake and body weight were then recorded for 18 d (d 8 -25 postoperatively).
CCK A receptor antagonist tests
Beginning 27 d postovariectomy, mice were adapted to a schedule where food was removed 2 h before the onset of the dark period, 0.2 ml 0.15 m NaCl was ip injected 30 min before dark, two preweighed food pellets were returned at dark onset, and food intake was measured 45, 90, and 180 min after dark onset. The effects on feeding of ip injections of 250 g devazepide (Merck, Sharpe, & Dohme Research Laboratories, West Point, PA), a potent and selective CCK A receptor antagonist (30) , were then compared with the effects of the 0.5% carboxymethylcellulose vehicle using a cross-over design. The selection of this design and devazepide dose were based on previously reported positive results in C57BL/6J mice (31).
CCK-induced c-Fos immunoreactivity
After the CCK A receptor antagonist tests, ad libitum food access was reinstated for 1 wk. The mice were then rerandomized into treatment groups, food-deprived at 0730 h, received ip injections of 4 g/kg CCK-8 at 0800 h, and at 0930 h were anesthetized by ip injections (0.2 ml) containing 0.15 mg ketamine (Ketaset, Fort Dodge, Inc., Fort Dodge, IA) and 0.1 mg xylazine (Rompun, Mobay, Inc., Shawnee, KS) and transcardially perfused with 4% paraformaldehyde in 0.1 m phosphate buffer solution. Brains were removed, blocked, postfixed for 2 h in the same 4% paraformaldehyde solution, and immersed for 2 d in 20% sucrose in 0.1 m phosphate buffer solution with 0.1% sodium azide. The hindbrain was cut in 40-m horizontal sections. When this is done, nearly the entire rostral-caudal extent of the nucleus of the solitary tract (NTS) is contained in sections that are just ventral to the area postrema (32, 33) . Alternate sections were processed for c-Fos immunocytochemistry and mounted on microscope slides. The section that was closest to the ventral extreme of the area postrema was identified, and it and the next ventral alternate section were used. The numbers of c-Fos-stained cells were counted in the medial halves of these sections from 1.5 mm anterior to the posterior extent of the fourth ventricle to 1.5 mm posterior to it, an area that includes the entire NTS, using NIH Image (version 1.4).
Carcass analysis
After lavage of the gastrointestinal tracts, the body compositions of the beheaded, perfused carcasses were analyzed for water, protein, and fat contents by Dr. Carol Boozer of the New York Obesity Research Center. Carcasses were autoclaved at 125 C in 50 ml distilled water for 30 min, cooled, and homogenized. Total body water was determined by drying duplicate 1-g samples of homogenate at 90 C to constant weight. Total carcass lipid was determined in triplicate by chloroform/methanol extraction of homogenate samples. Nitrogen was determined by the Kjeldahl method, and total carcass protein was calculated assuming a nitrogen/protein ratio of 0. 16 . Further details were previously reported (34) .
Data analysis
Daily body weights and food intakes from the last cycle before ovariectomy were analyzed for each of the two genotypes using one-way ANOVAs. As there were no significant effects of cycle day, mean weights were used for a preovariectomy value. These were compared between genotypes with t tests. Body weights and food intakes during the 18-d ad libitum feeding period were collapsed into six 3-d blocks. Cumulative body weight gains (grams per 3 d compared with the preovariectomy weights), food intakes during each block (grams per 3 d), and food intakes during the entire test (grams per 18 d) were analyzed with one-way ANOVAs. The mean number of cells expressing c-Fos immunoreactivity in the two sample hindbrain sections after CCK-8 or control treatment as well as data from each carcass analysis (protein, lipid, and water contents in grams) were analyzed with one-way ANOVAs. Food intakes after devazepide injection were analyzed with a split-plot, twoway ANOVA, with drug treatment as the within-subject variable.
Contrasts between individual means after significant ANOVA results were performed with Tukey's honestly significant difference test. Differences were considered significant when 2␣ Ͻ 0.05. Unless otherwise noted, all significance levels reported refer to the results of Tukey's honestly significant difference tests.
Results
Body weight
Before ovariectomy, the body weights of WT mice (17.6 Ϯ 0.3 g) and ␣ERKO mice (18.0 Ϯ 0.3 g) were not significantly different [t(35) ϭ 0.67; P ϭ NS]. After ovariectomy, vehicletreated WT mice gained significantly more weight than E2-treated WT mice or either group of ␣ERKO mice, whereas vehicle-treated ␣ERKO mice did not gain more weight than E2-treated ␣ERKO mice (Fig. 1 ). Significant differences first appeared 16 and 19 d postovariectomy [F(3,33) ϭ 4.01 and 4.88, respectively; P Ͻ 0.01], when vehicle-treated WT mice had gained more than vehicle-treated ␣ERKO mice (P Ͻ 0.05). After 22 and 25 d postovariectomy, vehicle-treated WT mice had gained more than each of the other three groups [F(3,33) ϭ 7.64 and 7.11, respectively; P Ͻ 0.001]. At d 25, the vehicle-treated WT mice had gained, on the average, 2.0 g more than E2-treated WT mice, whereas vehicle-treated ␣ERKO mice had gained 0.4 g less than E2-treated ␣ERKO mice. This difference in the effectiveness of E2 on weight gain was significant (P Ͻ 0.05).
Food intake
Before ovariectomy, WT mice ate about 10% more than ␣ERKO mice (4.40 Ϯ 0.16 vs. 3.94 Ϯ 0.14 g/d, respectively), but this difference was not quite statistically significant [t(35) ϭ 2.02; P Ͻ 0.051]. None of the analyses of 3-d food intakes after ovariectomy detected significant differences among the groups (data not shown). Analysis of the 18-d cumulative food intake, however, revealed that postovariectomy food intake paralleled body weight gain [F(3,32) ϭ 4.28; P Ͻ 0.02; Table 1 ]. That is, vehicle-treated WT mice ate more than E2-treated WT mice, whereas vehicle-treated ␣ERKO mice did not eat more than E2-treated ␣ERKO. Furthermore, the mean vehicle-E2 difference was significantly larger in WT than ␣ERKO mice.
CCK A receptor antagonism
Intraperitoneal injection of 250 g devazepide significantly increased 180-min food intake in E2-treated WT mice, but was ineffective in vehicle-treated WT mice and in both groups of ␣ERKO mice [F(3,26) ϭ 3.01; P Ͻ 0.05; Fig. 2] . The stimulatory effect of devazepide in E2-treated WT mice was larger than in any other group. The effects of devazepide at 45 and 90 min were not significant (data not shown).
CCK-induced c-Fos immunoreactivity
Intraperitoneal injection of 4 g/kg CCK-8 increased the number of NTS cells expressing c-Fos immunoreactivity in all four groups [F(7,23) ϭ 61.05; P Ͻ 0.0001]. This increase, however, was much larger in E2-treated WT mice than in vehicle-treated WT mice, whereas there was no such differential effect of E2 in ␣ERKO mice (Fig. 3) . Typical photomicrographs are shown in Fig. 4 .
Carcass analysis
In WT mice body lipid content was significantly less after E2 treatment than after vehicle treatment, but not in ␣ERKO mice [F(3,23) ϭ 5.90; P Ͻ 0.005; Table 2 ]. The vehicle-E2 differences in lipid contents were not different between the genotypes. Body water and protein contents did not differ significantly among the four groups [F(3,23) ϭ 1.44 and 0.58, respectively].
Discussion
Feeding, like sexual behavior, locomotor activity, and other behaviors, is potently controlled by the hypothalamicpituitary-gonadal axis in adult females of many species. In mice and rats, normal levels of E2 tonically decrease basal meal size and food intake throughout the ovarian cycle and phasically decrease meal size and food intake during the estrous phase of the cycle (2-5, 10 -14) . Release from these inhibitions by ovariectomy increases meal size, feeding, adiposity, and body weight. Here we used the ␣ERKO mouse to investigate for the first time the ER mechanism mediating these feeding effects. We report that daily food intake, adiposity and body weight, and the behavioral and neural responsivity of the CCK satiation-signaling system were all g). Data are the food intake (mean Ϯ SEM) during a 3-h feeding test beginning at dark onset (n ϭ 7-11/group). Devazepide increased feeding in E2-treated WT mice, but not in vehicle-treated (V) WT mice or in either group of ␣ERKO mice. *, P Ͻ 0.05 vs. control. affected by E2 treatment in ovariectomized WT mice, whereas none of these measures was affected by E2 treatment in ovariectomized ␣ERKO mice. Therefore, ER␣ is a necessary component of the E signaling pathway mediating each of these effects in female mice, and ER␤ alone is not sufficient for any of them.
E signaling and weight regulation
In young adult mice and rats, ovariectomy leads to a weight gain of 10 -25%, almost all in the form of adipose tissue (4, 5, 8, 12, 35, 36) . The main cause of this weight gain is typically a tonic increase in feeding, although reductions in physical activity and altered metabolism also contribute (36) . This increase in feeding is mediated by an increase in meal size, with no change or a decrease in meal frequency (3, 12, 13 ). E2 appears to cause these feeding effects, because E2 treatment is sufficient to normalize meal patterns and adiposity (3, 12, 13) . In the present study ovariectomized wildtype mice that received E2 treatment ate less, had a smaller percentage of body fat, and gained less body weight than mice that did not receive E2. In contrast, ovariectomized ␣ERKO mice that received E2 were not significantly different from mice that did not receive E2 in any of these measures. Thus, ER␣ is necessary, and ER␤ alone is not sufficient for the restraining effects of E2 on basal level of food intake, adiposity, and body weight in female mice. Despite the differences in the feeding and body weight responses of WT and ␣ERKO mice reported here, there was no difference in the body weights of the two genotypes before ovariectomy. This is consistent with two studies of the development of adiposity and body weight through the life span in ␣ERKO mice (6, 9) and one study in transgenic mice with a null mutation of the gene encoding aromatase, the enzyme mediating E synthesis (7) . In these studies both male and female knockouts increased adiposity and body weight slowly, so that weight differences were evident only when the mice were 3 months of age or older. In ␣ERKO mice food intake was measured only in males and was not different from that in WT mice (6) ; in aromatase knockouts food intake decreased in both males and females (7) . Thus, changes in metabolism or physical activity apparently produced the weight and adiposity increases. The lack of an increase in food intake in these studies is consistent with our finding that the daily food intake of ␣ERKO mice was similar to that of E2-treated ovariectomized WT mice and less than that of untreated ovariectomized WT mice. The apparent discrepancy between the tonic feeding effects of genetic disruption of the E-signaling system and the effects of ovariectomy in adult animals clearly requires research.
E signaling and feeding in intact cycling rats and mice
E2 also produces a cyclic decrease in meal size and food intake during the estrous phase of the ovarian cycle in rats and mice (13, 14, 19, 37) . Several results indicate that this inhibition is due in large part to a cyclic increase in the potency of the negative feedback control of meal size that originates from small intestinal food stimuli that cause the release of CCK (3, 10, 15, 19, 20) . The most direct evidence is that antagonism of endogenous CCK by administration of the selective CCK A receptor antagonist devazepide (30) produced larger increases in meal size during estrus than diestrus in intact rats (19) and during the phase of cyclic E2 treatment that modeled estrus than during the phase that modeled diestrus in ovariectomized rats (10). Here we demonstrated a similar E2-dependent increase in the satiating potency of endogenous CCK in ovariectomized WT mice. In contrast, devazepide did not increase feeding in either E2-treated or vehicle-treated ␣ERKO mice. Thus, ER␣ is necessary, and ER␤ alone is not sufficient, for the increase in CCK's satiating potency by E2 in female mice. Because we tested devazepide's effect only in ovariectomized mice, we can only speculate that in mice, as in rats, the E2-dependent increase in CCK's satiating action in ovariectomized animals parallels a cyclic decrease in CCK's satiating potency during the estrous phase of the ovarian cycle in intact animals.
Neural mechanisms of the estrogenic control of feeding
Peripheral CCK-8 injections selectively increased the number of NTS cells expressing c-Fos-like immunoreactivity, a marker for neuronal activity, in E2-treated ovariectomized WT mice significantly more than in vehicle-treated WT mice. Similarly, CCK-8 injection and food ingestion both increased NTS c-Fos in E2-treated ovariectomized rats, but not in untreated ovariectomized rats (38, 39) . The NTS is the first central relay of the vagal afferent neurons that carry negative feedback information controlling meal size from CCK's site of action in the gut to the brain. Thus, that E2 increased CCK-8-mediated c-Fos in the NTS suggests that the increased potency of the CCK signaling system may originate from altered information processing in the initial, more sensory part of the neuronal network controlling meal size. The lack of effect of E2 on CCK-8-induced c-Fos in the NTS of ␣ERKO mice indicates that ER␣ is necessary for this apparent increase in neuronal information processing and that ER␤ alone is not sufficient for it.
E2 presumably acts centrally to inhibit feeding, but neither the present nor previous data disclose the site(s) of the ER␣ that participates in the control of feeding, CCK satiation, body weight, or adiposity in mice or rats. ER␣ has been localized in neurons in numerous brain sites implicated in the control of feeding, including the NTS and various hypothalamic and forebrain loci (40 -42) . As ER␣ is expressed in the NTS, all of the effects of E2 on feeding in ovariectomized mice that we have reported, including the increase in c-Fos expression, may have originated from activation of ER␣ in the NTS. It is also possible that the crucial population of ER␣ is located more rostrally and that the increase in CCK-stimulated NTS c-Fos resulted indirectly from a descending neural projection.
Finally, the selective stimulatory effect of E2 on CCK-8-induced NTS c-Fos expression in WT mice also suggests that the similar selective effect of antagonism of endogenous CCK with devazepide on feeding was not an artifact of the different baseline levels of food intake in the feeding tests. That is, because baseline food intake was less in the E2-treated WT mice, it could be supposed that ceiling effects in the other groups masked similar stimulatory effects of devazepide, but the c-Fos tests produced the same pattern of results in the absence of any such baseline differences. This parallels more direct lines of evidence indicating that the cyclic increases in endogenous CCK's satiating potency in intact and E2-treated ovariectomized rats are not secondary to baseline differences in food intake (10, 19) .
Summary and comment
We demonstrated that E2 treatment reduced food intake, body weight, and adiposity; increased the stimulation of feeding induced by antagonism of endogenous CCK; and increased the expression of c-Fos protein induced by CCK injection in ovariectomized WT mice, but had none of these effects in ovariectomized ␣ERKO mice. These data provide the first direct demonstration of a necessary role of ER␣ in the estrogenic control of feeding in female mice and extend recent reports of body weight regulation in mice with null mutations of ER␣ (6, 9) . This parallels the apparently necessary contributions of ER␣ to sexual receptivity in female mice (1, 28, 29) , to reproductive and aggressive behaviors in male and female mice (28, 29, 43, 44) , and to many physiological actions of E2 (21) .
The demonstration that ER␣ is necessary and that ER␤ alone is not sufficient for E2's effects on feeding and body weight in female mice does not rule out a participatory role for ER␤ in the normal physiological control of these functions. This issue will have to be evaluated using more sophisticated methods than simple screening tests in single gene null mutant, or knockout, animals. Most genetic effects, including E responsivity (45) , are remarkably pleiotropic, so large arrays of genes normally interact to produce the phenotype under consideration (46, 47) . Thus, although ER␤ or other ER species may not be sufficient to produce the phenotypes that we studied, they may usually make important contributions. Genes with no clear relationship to the phenotype under study may also have biologically significant influences. This includes background effects, i.e. effects of the strain of mouse, which have been demonstrated both for pharmacological actions of E2 (47) and for the consequences of null mutation of ER␣ (44) . In addition, individual experience may alter the influence of particular genes, as was recently shown for the role of ER␤ in the control of aggressive behavior (48) . Finally, we suggest that the ER␣-mediated effects on feeding and body weight that we have revealed here result from activational effects of circulating E2. We cannot, however, exclude the possibility that there were important contributions of developmental abnormalities due to the lack of organizational effects mediated by ER␣ (21, 27) .
